4th Annual Lung Cancer Awareness Provider Dinner

Posted by & filed under Uncategorized.

4th Annual Lung Cancer Awareness Provider Dinner Dr. Jason Porter is hosting an insightful evening of discussion, collaboration, and networking focused on the latest advancements in lung cancer research, treatment, and care. All surrounding providers are invited to join! Date: Monday, December 2, 2024 Location: Capital Grille – Memphis Happy Hour: 6pm / Dinner &… Read more »

Lung Screening

Posted by & filed under Uncategorized.

Patients and referring providers can schedule an appointment for a low-dose CT scan. Patients must meet the following criteria: Between the ages of 50 – 77 Smoke for at least 20 years at least 1 pack a day If the patient has stopped smoking, must have quit within the last 15 years Must be asymptomatic... Read more »

2024 Think Pink Luncheon

Posted by & filed under Uncategorized.

Our West family is so proud to support the annual Think Pink Memphis luncheon! <br> This weekend, Dr. Jason Porter and Dr. Carmel Verrier participated in the expert panel discussion, sharing information about: Screening guidelines Current treatment and surgical options Importance of physical therapy for pre- and post-surgery Resources available across the Mid-South <br> This… Read more »

The Latest in Lung Cancer Research with Dr. Jason Porter

Posted by & filed under Uncategorized.

Tuesday, September 19 at 5pm EST Join Dr. Jason Porter for a live, dynamic discussion about the critical role of biomarker testing and clinical trials in lung cancer! Dr. Porter will partner with Estelamari Rodriguez, MD, MPH from the University of Miami’s Sylvester Comprehensive Cancer Center and moderator Terric Conneran, Founder of KRAS Kickers, to… Read more »

Exciting News in Lung Cancer Treatment, ft. Dr. Jason Porter

Posted by & filed under Uncategorized.

Exciting News in Lung Cancer Treatment   Dr. Jason Porter joins Dr. Maya Khalil, Dr. Brian Mitzman, and Dr. Rami Manochakian in discussing the strides made in improving patient outcomes with immunotherapy and targeted therapies for non-small cell lung cancer (NSCLC).   The group talks about several new clinical trials demonstrating promising results for high… Read more »